This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057108321089v1 13/7/591    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Yoon, J.-J. Articles by Plemper, R. K. PubMed PubMed Citation Articles by Yoon, J.-J. Articles by Plemper, R. K. Social Bookmarking                   What's this?

High-Throughput Screening-Based Identification of Paramyxovirus Inhibitors

Emory University

^* To whom correspondence should be addressed. E-mail: rplempe{at}emory.edu.

	Abstract

Several members of the paramyxovirus family constitute major human pathogens that, collectively, are responsible for major morbidity and mortality worldwide. In an effort to develop novel therapeutics against measles virus (MV), a prominent member of the paramyxovirus family, the authors report a high-throughput screening protocol that uses a nonrecombinant primary MV strain as targets. Implementation of the assay has yielded 60 hit candidates from a 137,500-entry library. Counterscreening and generation of dose-response curves narrows this pool to 35 compounds with active concentrations 15.3 µM against the MV-Alaska strain and specificity indices ranging from 36 to >500. Library mining for structural analogs of several confirmed hits combined with retesting of identified candidates reveals a high accuracy of primary hit identification. Eleven of the confirmed hits interfere with viral entry, whereas the remaining 24 compounds target postentry steps of the viral life cycle. Activity testing against selected members of the paramyxovirus family reveals 3 patterns of activity: 1) exclusively MV-specific blockers, 2) inhibitors of MV and related viruses of the same genus, and 3) broader range inhibitors with activity against a different Paramyxovirinae genus. Representatives of the last class may open avenues for the development of broad-range paramyxovirus inhibitors through hit-tolead chemistry. (Journal of Biomolecular Screening XXXX:xx-xx)

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?